Skip to main content
. Author manuscript; available in PMC: 2026 Sep 5.
Published before final editing as: J Acad Nutr Diet. 2026 Aug 19:156830. doi: 10.1016/j.jand.2026.156830

Table 3:

Spearman correlations between percent energy from fat, inflammation, circulating tumor cells, and circulating tumor DNA in the Exercise and Colorectal Cancer Treatment (EXACT) trial (N=57)

Soluble factor Percent energy from fat
Unadjusted Adjusted (age, sex, race, cancer stage, MVPAa) Fully adjusted (age, sex, race, cancer stage, MVPAa, VATb)
r 95% CI r 95% CI r 95% CI
High-sensitivity c-reactive protein (hsCRP) (mg/L) −0.04 −0.30-0.22 −0.007 −0.32-0.29 0.006 −0.32-0.31
Interleukin-6 (IL-6) (pg/mL)c 0.19 −0.09-0.43 0.16 −0.17-0.45 0.12 −0.21-0.46
Soluble interleukin-6 receptor (sIL-6r) (pg/mL)d 0.32 0.06-0.53 0.26 −0.03-0.51 0.24 −0.04-0.50
Tumor necrosis factor alpha (TNFα) (pg/mL)e 0.23 −0.04-0.46 0.16 −0.14-0.42 0.06 −0.23-0.35
Soluble tumor necrosis factor alpha receptor 1 (sTNFr1) (pg/mL)f 0.32 0.06-0.53 0.25 −0.009-0.48 0.20 −0.07-0.44
Soluble tumor necrosis factor alpha receptor 2 (sTNFr2) (pg/mL)g 0.34 0.09-0.55 0.32 0.06-0.55 0.28 0.02-0.51
Interleukin-2 (IL-2) (pg/mL)h 0.15 −0.15-0.42 0.04 −0.26-0.35 0.001 −0.29-0.33
Soluble interleukin-2 receptor alpha (sIL-2rα) (pg/mL)i 0.29 0.03-0.51 0.24 −0.03-0.47 0.20 −0.05-0.42
Interleukin-10 (IL-10) (pg/mL)j −0.01 −0.27-0.25 −0.02 −0.30-0.28 −0.08 −0.37-0.23
Interleukin-23 (IL-23)(pg/mL)k −0.08 −0.33-0.18 −0.11 −0.39-0.21 −0.17 −0.44-0.15
Soluble receptor for advanced glycation end-products (sRAGE) (pg/mL)l 0.23 −0.07-0.48 0.25 −0.09-0.53 0.22 −0.10-0.51
Circulating tumor cells (CTCs) (cells/mL) 0.19 −0.09-0.43 0.22 −0.03-0.46 0.22 −0.03-0.47
Circulating tumor DNA (ctDNA) (%) −0.03 −0.29-0.24 −0.01 −0.32-0.30 −0.02 −0.34-0.29
a

Moderate-to-vigorous physical activity

b

Visceral adipose tissue

c

To convert pg/mL interleukin-6 to pmol/L, multiply by 0.0481

d

To convert pg/mL soluble interleukin-6 receptor to pmol/L, multiply by 0.0237

e

To convert pg/mL tumor necrosis factor alpha to pmol/L, multiply by 0.0575

f

To convert pg/mL soluble tumor necrosis factor alpha receptor 1 to pmol/L, multiply by 0.0182

g

To convert pg/mL soluble tumor necrosis factor alpha receptor 2 to pmol/L, multiply by 0.0133

h

To convert pg/mL interleukin-2 to pmol/L, multiply by 0.0667

i

To convert pg/mL soluble interleukin-2 receptor alpha to pmol/L, multiply by 0.0403

j

To convert pg/mL interleukin-10 to pmol/L, multiply by 0.0556

k

To convert pg/mL interleukin-23 to pmol/L, multiply by 0.0169

l

To convert pg/mL soluble receptor for advanced glycation end-products to pmol/L, multiply by 0.0294